Gerresheimer, a leading provider of healthcare and beauty solutions and drug delivery systems for pharma, biotech and cosmetics, reports double-digit growth in revenues and adjusted EBITDA for FY 2022. Revenue rose organically by 16.2%, driven by all divisions. Adjusted EBITDA grew organically by 10.2%.
Gerresheimer, the leading global provider of healthcare, beauty and drug delivery systems for pharma, biotech and cosmetics, today announced a joint venture with Corning (NYSE: GLW), a leading innovator in materials science and manufacturing, to increase global access to the Velocity® Vial technology platform, addressing the need for a high-quality and cost-effective injectable drug filling process.
Gerresheimer presents its new Clinical Trial Kit at Pharmapack in Paris. This kit consists of sterile Gx RTF vials in nest and tub or tray with matching closures and is tailored to requirements to support the development of new drugs, vaccines and biologics in early phases. The Clinical Trial Kit is suitable for small batch manufacturing from first line trials to validation and clinical batches. It can be ordered in six different configurations of Gx RTF Glass Vials. Kits including Gx Elite and Gx RTF COP vials will follow soon.
Top rating recognises commitment to creating a positive impact on climate change
With innovative, solution-oriented, and sustainable developments, the Gerresheimer team presents itself at Pharmapack and looks forward to visits from the trade public. The range includes solutions, products and delivery systems for medications, vaccines, or highly effective biologics. In the presentation "Services beyond product" Gerresheimer presents new products and services.
Health Canada certifies Sofgen Pharmaceuticals in Canadian Good Manufacturing Practices (GMP) for our compliance with the Food and Drug Regulations at its facilities. This new permit allows our production areas to manufacture, package, label, distribute, import, wholesale, and/or test a drug.
At today’s Capital Markets Day 'Generating Sustainable Value', Gerresheimer, a leading provider of healthcare and beauty solutions and drug delivery systems for pharma, biotech and cosmetics, reaffirmed its growth agenda and increased its revenue and adjusted EBITDA guidance. The company continues to execute consistently its formula g strategy while actively managing global, external challenges.
Did you know that 7-11 November is World Quality Week? NSF’s Health Sciences team are proud to be taking part.
The new EZ-fill Smart™ is an evolution of Stevanato Group’s groundbreaking EZ-fill® platform, and it brings new advancements that can create significant enhancements to customer product offerings amid growing demand for RTU vials.
To accelerate and de-risk drug development, Gerresheimer and Nelson Labs announce a formal strategic partnership on analytical and drug compatibility lab testing for the pharmaceutical and biotech industries.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.